Opioid use and risk of liver fibrosis in HIV/hepatitis C virus-coinfected patients in Canada-Reference-Cited by-同舟云学术

Opioid use and risk of liver fibrosis in HIV/hepatitis C virus-coinfected patients in Canada

Author:

Brunet L¹,Moodie EEM¹,Cox J¹²,Gill J³,Cooper C⁴⁵,Walmsley S⁵⁶,Rachlis A⁵⁷,Hull M⁵⁸,Klein MB²⁵,

Affiliation:

1. Department of Epidemiology, Biostatistics and Occupational Health; McGill University; Montreal Quebec Canada

2. Chronic Viral Illness Service, Montreal Chest Institute; McGill University Health Centre; Montreal Quebec Canada

3. Southern Alberta HIV Clinic, Calgary; Alberta Canada

4. The Ottawa Hospital-General Campus; Ottawa Ontario Canada

5. CIHR Canadian HIV Trials Network (CTN); Vancouver British Columbia Canada

6. University Health Network; University of Toronto; Toronto Ontario Canada

7. Sunnybrook & Women's College Health Sciences Centre; University of Toronto; Toronto Ontario Canada

8. BC Centre for Excellence in HIV/AIDS; Vancouver British Columbia Canada

Funder

Fonds de recherche Santé-Québec, Réseau SIDA/maladies infectieuses

Canadian Institutes of Health Research

Canadian HIV Trials Network, Canadian Institutes of Health Research

Publisher

Wiley

Subject

Pharmacology (medical),Infectious Diseases,Health Policy

Reference50 articles.

1. Therapeutic use, abuse, and nonmedical use of opioids: a ten-year perspective;Manchikanti;Pain Physician,2010

2. Determinants of increased opioid-related mortality in the United States and Canada, 1990-2013: a systematic review;King;Am J Public Health,2014

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献